Of note, MN1 exerts a pro-tumor effect through the XIST/miR-15a-5p/MN1/FZD2 signaling axis, and its significantly high expression is observed in female patients with poor prognosis, which may be an important molecular basis for the gender difference in BLCA (70). Here, FZD2 is linked to bladder transitional cell carcinoma.